Bunge Global stock holds after 2025 earnings and merger update

Bunge Global stock is anchored by its 2025 earnings base and the Viterra merger process, with 2025 revenue, adjusted EPS, and 2025 guidance still framing the story.

Bunge Global (US12185T1043) is framed by its 2025 earnings base, with net sales of $51.19 billion in fiscal 2025, adjusted EPS of $7.24, and operating cash flow of $2.61 billion all still central to the stock case. The company also said on 30 April 2025 that it expected adjusted EPS of about $7.75 for 2025 and planned to complete the Viterra transaction, making the merger timetable a key market reference.

2025 earnings base matters

For Bunge Global stock, the most concrete recent operating backdrop is the 2025 annual report: net sales were $51.19 billion, adjusted earnings per share were $7.24, and operating cash flow reached $2.61 billion. Those figures give investors a firm baseline for judging any later margin change or integration effect.

Net sales in 2025 were lower than the $59.37 billion reported for 2024, while adjusted EPS improved from $7.03 to $7.24 over the same period. That combination points to a business that kept earnings resilient even as top-line volume and pricing conditions shifted.

Viterra is the strategic hinge

The other major reference point is the planned combination with Viterra, which Bunge described in its 2025 quarterly update as expected to close during 2025. That transaction matters because it would expand origination, handling, and processing scale across grains and oilseeds, three areas that directly affect Bunge Global stock valuation.

Bunge also said in its 30 April 2025 release that it expected adjusted EPS of about $7.75 for 2025, which put management guidance above the $7.24 adjusted EPS actually delivered in fiscal 2025. The gap between guidance and delivered earnings is a useful marker for how integration timing and commodity conditions can move the stock narrative.

Revenue down, cash flow up

The 2025 numbers are mixed in a way investors can actually use. Revenue fell from $59.37 billion in 2024 to $51.19 billion in 2025, but operating cash flow still came in at $2.61 billion, showing the company continued to convert earnings into cash.

That matters because agribusiness margins are often driven more by spread capture and working capital than by simple sales growth. In Bunge Global stock, the balance between lower sales and steady cash generation is the more relevant comparison than headline turnover alone.

Oilseeds stay central

Bunge’s oilseed processing and merchandising business remains the core product engine behind these results. The annual report and quarterly updates both show that the company is still heavily exposed to crop flows, crushing spreads, and export demand across its global network.

That product mix is what makes the Viterra transaction strategically important: the combined platform would be larger in origination and storage, while also retaining exposure to the same commodities that drove the 2025 earnings base. For Bunge Global stock, that means the operating debate stays tied to execution, not a new business model.

Stock level and valuation frame

Bunge Global shares closed at $83.57 on 18 July 2026, leaving the stock above the level implied by the latest full-year earnings base but still tied to commodity-cycle sentiment. Market capitalization stood at about $11.9 billion on the same date, a size that reflects both the earnings scale and the uncertainty around post-merger integration.

The share price and market value make the 2025 fundamentals more than backward-looking accounting. They remain the starting point for any valuation view on Bunge Global stock as the company works through the next phase of portfolio and merger execution.

Company: Bunge Global S.A.
ISIN: US12185T1043
Ticker: NYSE: BG
Trading venue: NYSE
Price (as of 18 July 2026, 16:00 ET): $83.57
Market capitalization: $11.9 billion (as of 18 July 2026)
Sector / Industry: Consumer Staples / Food Products
Index membership: S&P 500